Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1999 Spring;20(3):39-54.

Effect of insurance on prescription drug use by ESRD beneficiaries

Y C Shih  1
Affiliations

Effect of insurance on prescription drug use by ESRD beneficiaries

Y C Shih. Health Care Financ Rev. 1999 Spring.

Abstract

In this article the author reviews the prescription drug coverage policy in the Medicare End Stage Renal Disease (ESRD) program and examines the relationship between secondary insurance status and the number of medications prescribed for dialysis patients who had Medicare as their primary payer. Negative binomial models were used to examine this relationship. Findings in this study indicate that the number of secondary payers has a significant impact on the number of prescription drugs received by Medicare ESRD patients. Further research is needed to determine whether Medicare beneficiaries without secondary insurance are obtaining fewer prescriptions than needed or if those with greater coverage are obtaining more than needed.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Number of Medications, by Presence of Secondary Insurance
See this image and copyright information in PMC

References

    1. Anderson RJ, Melikian DM, Gambertoglio JG, et al. Prescribing Medication in Long-Term Dialysis Units. Archives of Internal Medicine. 1982;142:1305–1308. - PubMed
    1. Erslev AJ. Erythropoietin. New England Journal of Medicine. 1991;324:1339–1344. - PubMed
    1. Grabe DW, Low CL, Baile GR, et al. Evaluation of Drug-Related Problems in an Outpatient Hemodialysis Unit and the Impact of a Clinical Pharmacist. Clinical Nephrology. 1997;47:117–121. - PubMed
    1. Hausman J, Hall BH, Griliches Z. Econometric Models for Count Data With An Application to the Patients - R&D Relationship. Econometrica. 1984 Jul;52(4):909–938.
    1. Health Care Financing Administration. Medicare and Medicaid Statistical Supplement 1995. Washington, DC.: U.S. Government Printing Office; 1995. HCFA Pub. No. 03374.

MeSH terms

LinkOut - more resources